Legato Capital Management LLC grew its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 26.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,570 shares of the health services provider's stock after buying an additional 8,436 shares during the quarter. Legato Capital Management LLC owned approximately 0.07% of Maximus worth $2,766,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new stake in shares of Maximus in the 4th quarter valued at about $1,169,000. Xponance Inc. increased its holdings in shares of Maximus by 4.1% during the fourth quarter. Xponance Inc. now owns 8,526 shares of the health services provider's stock worth $636,000 after purchasing an additional 336 shares during the period. American Century Companies Inc. increased its holdings in shares of Maximus by 63.0% during the fourth quarter. American Century Companies Inc. now owns 21,547 shares of the health services provider's stock worth $1,608,000 after purchasing an additional 8,332 shares during the period. AXQ Capital LP bought a new position in shares of Maximus during the fourth quarter worth approximately $206,000. Finally, KLP Kapitalforvaltning AS bought a new position in Maximus in the fourth quarter valued at approximately $1,821,000. 97.21% of the stock is owned by institutional investors.
Insider Transactions at Maximus
In related news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is currently owned by insiders.
Maximus Price Performance
Maximus stock traded down $0.21 during mid-day trading on Friday, reaching $73.42. The company had a trading volume of 556,595 shares, compared to its average volume of 388,516. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. The company has a market cap of $4.14 billion, a P/E ratio of 14.60 and a beta of 0.61. The business has a fifty day simple moving average of $71.45 and a 200 day simple moving average of $70.72.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.56% and a return on equity of 23.37%. Maximus's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.57 earnings per share. On average, equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.63%. Maximus's payout ratio is 23.86%.
Analyst Ratings Changes
Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Read Our Latest Stock Analysis on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.